BRD8518, a PCSK9 inhibitor (EC50=0.23 µM), effectively lowers lipid levels by upregulating LDLR expression and enhancing the uptake of LDL. This compound is utilized in cardiovascular disease research.
Molecular Weight:
607.62
CAS Number:
[1565828-01-4]
Formula:
C33H32F3N3O5
Target:
LDLR
T200399
* VAT and and shipping costs not included. Errors and price changes excepted